Article Publish Status: FREE
Abstract Title:

Considering the methodological limitations in the evidence base of antidepressants for depression: a reanalysis of a network meta-analysis.

Abstract Source:

BMJ Open. 2019 Jun 27 ;9(6):e024886. Epub 2019 Jun 27. PMID: 31248914

Abstract Author(s):

Klaus Munkholm, Asger Sand Paludan-Müller, Kim Boesen

Article Affiliation:

Klaus Munkholm


OBJECTIVES: To investigate whether the conclusion of a recent systematic review and network meta-analysis (Cipriani) that antidepressants are more efficacious than placebo for adult depression was supported by the evidence.

DESIGN: Reanalysis of a systematic review, with meta-analyses.

DATA SOURCES: 522 trials (116 477 participants) as reported in the systematic review by Ciprianiand clinical study reports for 19 of these trials.

ANALYSIS: We used the Cochrane Handbook's risk of bias tool and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to evaluate the risk of bias and the certainty of evidence, respectively. The impact of several study characteristics and publication status was estimated using pairwise subgroup meta-analyses.

RESULTS: Several methodological limitations in the evidence base of antidepressants were either unrecognised or underestimated in the systematic review by Cipriani. The effect size for antidepressants versus placebo on investigator-rated depression symptom scales was higher in trials with a 'placebo run-in' study design compared with trials without a placebo run-in design (p=0.05). The effect size of antidepressants was higher in published trials compared with unpublished trials (p<0.0001). The outcome data reported by Ciprianidiffered from the clinical study reports in 12 (63%) of 19 trials. The certainty of the evidence for the placebo-controlled comparisons should be very low according to GRADE due to a high risk of bias, indirectness of the evidence and publication bias. The mean difference between antidepressants and placebo on the 17-item Hamilton depression rating scale (range 0-52 points) was 1.97 points (95% CI 1.74 to 2.21).

CONCLUSIONS: The evidence does not support definitive conclusions regarding the benefits of antidepressants for depression in adults. It is unclear whether antidepressants are more efficacious than placebo.

Study Type : Meta Analysis
Additional Links

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2022 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.